Weight Loss & MetabolicPeer Reviewed

Glucagon-Like Peptide 1 Receptor Agonists (GLP1-RA) and the Clinical Outcomes of Inflammatory Bowel Disease (IBD): A Systematic Review and Meta-analysis.

Authors (12)
Ahmed B Bayoumy
Lindsay M ClarkeDivision of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Parakkal DeepakDivision of Gastroenterology and Inflammatory Bowel Diseases Center, Washington University in Saint Louis School of Medicine, St Louis, Missouri.
Aakash DesaiDivision of Gastroenterology, Hepatology, and Nutrition, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
Journal of Crohn's & colitis
Unknown
Published
Oct 13, 2025
View Original

Abstract

Abstract not available - data parsing issue resolved

Keywords

Crohn’s diseaseGLP1-RAcorticosteroid usedrug repurposinghospitalizationinflammatory bowel diseasemeta-analysisobesitysystematic reviewtype 2 diabetes mellitusulcerative colitis

Article Metrics

Sourcepubmed

Related Research

Explore more articles in this research category to discover related studies and findings.

View more in Weight Loss & Metabolic